It looks like you are visiting CMR Surgical from the United States of America.
Please select the following:

I am a US healthcare professional practicing in the United States of America I am NOT a US healthcare professional practicing in the United States of America
March 22, 2018
CMR Surgical awarded for engineering excellence
March 22, 2018
CMR Surgical awarded for engineering excellence

Cambridge, UK, 22 March 2018 | CMR Surgical, the Cambridge-based company developing the next-generation surgical robot, has been awarded for engineering excellence in Business Weekly’s 2018 Awards.

Press Office

T: +44 01223 755801

Announced last night at Queens’ College, Cambridge, the Business Weekly Awards recognise the best of the region’s businesses. The Engineering Excellence award is in recognition of a company ‘that is deemed to have done most for the cause of industry in the last 12 months’.

CMR Surgical is developing Versius; a surgical robot designed to meet the complex requirements of laparoscopic surgery. It is inspired by the human arm and has remarkable dexterity, flexibility and reach, enabling a new paradigm in surgical experience – driving CMR Surgical’s vision in making minimal access surgery available to all.

Luke Hares, CMR Surgical’s Chief Technology Officer said, “As a company located in Cambridge, Europe’s innovation capital, we’re thrilled to win the Engineering Excellence award this year. It is testament to the dedication of our hard-working highly-skilled team, determined to revolutionise surgery with the launch of Versius.”

CMR Surgical has more than doubled in size in the last year. It now employs more than 170 people in Cambridge and expects to continue its significant growth in the next year.


About CMR Surgical

CMR Surgical is a British private limited company developing the next-generation universal robotic system, Versius®, for minimal access surgery.

The vision behind CMR Surgical is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics while also addressing the six million people who still undergo open surgery each year.

Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025[i].

CMR Surgical, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base of specialist and generalist investors. The Company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC® (‘UL’), and the status as a UL Registered Firm, in September 2015.

For further information, please visit

About Versius, the CMR Surgical robotic system

Designed to meet the complex requirements of laparoscopic surgery, Versius’ compact size fits easily into the existing surgical workflow, while its ergonomic console design allows surgeons to work in a way that reduces physical and mental effort.  Intended to be used across a range of surgical specialties, the versatility and portability of Versius, enabled by a unique and patented four-axis wrist joint, expands the potential for higher utilisation. The versatility of the system and compelling commercial model allows healthcare providers to offer the benefits of robotic-assisted procedures in a cost-effective way.

[i] Industry Forecast, Accuray Research